🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Florid › Orlando

Etid klinik pou Maladi kadyovaskilè nan Orlando, FL

14 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Florida Institute For Clinical Research, LLC, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi lwen
  • Omega Research Orlando, Altamonte Springs · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Florida Institute for Clinical Research, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Ap rekriteFaz 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi lwen
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Orlando
  • Clinical Trial Site, Winter Park · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Ap rekriteFaz 3
  • Clinical Research Site, Kissimmee · 16 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • Advent Health, Orlando
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Ap rekriteFaz 2
  • Clinical Research Site, Kissimmee · 16 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Ap rekriteEtid obsèvasyon
  • Arnold Palmer Hospital for Children, Orlando
  • Nemours Children's Hospital, Orlando
Laj 7 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Orlando
  • Research Site, Orlando
  • Research Site, Orlando
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Ap rekriteFaz 3
  • Clinical Site Partners Orlando dba Flourish Research, Winter Park · 5 mi lwen
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Ap rekriteFaz 3
  • FC Site Partners Miami, Winter Park · 5 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911

SPYRAL GEMINI Pilot Study

Ap rekrite
  • Orlando Health Heart & Vascular Institute, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Ap rekrite
  • Advent Health Hospital, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Ap rekriteFaz 3
  • AdventHealth, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.